RedHill Biopharma (RDHL) Other Non-Current Liabilities (2011 - 2026)
RedHill Biopharma (RDHL) reported Other Non-Current Liabilities of $6.47 million for the quarter ended Jun 30, 2026, down 41.2% from $11 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, RedHill Biopharma posted Other Non-Current Liabilities of $456,000, down 67.9% from the prior year.
- Other Non-Current Liabilities has a three-year compound annual growth rate of -44.2% (years ended Dec 2022 to Dec 2025).
- By year, Other Non-Current Liabilities came in at $1.42 million in the year ended Dec 31, 2024 (+91.8%), $741,000 in the year ended Dec 31, 2023 (-71.7%) and $2.62 million in the year ended Dec 31, 2022.
- Five-year quarterly Other Non-Current Liabilities spans a low of $456,000 in the quarter ended Dec 31, 2025 and a high of $11 million in the quarter ended Jun 30, 2025.
- Year over year, Other Non-Current Liabilities gained in two of the last four quarters, with growth averaging 78.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.47 Mn |
| Dec 31, 2025 | 456,000.00 |
| Jun 30, 2025 | 11.00 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Jun 30, 2024 | 2.54 Mn |
| Dec 31, 2023 | 741,000.00 |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 1.63 Mn |
| Dec 31, 2022 | 2.62 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 6.07 Mn |
| Sep 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 13,000.00 |
| Mar 31, 2019 | 1.32 Mn |
| Dec 31, 2018 | 344,000.00 |
| Sep 30, 2018 | 2.54 Mn |
| Jun 30, 2018 | 2.07 Mn |
| Mar 31, 2018 | 398,000.00 |
| Dec 31, 2017 | 448,000.00 |
| Sep 30, 2017 | 4.31 Mn |
API Access
RedHill Biopharma Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();